Skip to main content
FDA OKs Azurity's amlodipine benzoate oral suspension formula
7/12/2019

Azurity Pharmaceuticals' Katerzia, or amlodipine benzoate, has received the FDA's approval. The drug is an oral liquid suspension formulation used to treat hypertension in patients age 6 and older.

Full Story: